港通医疗
(301515)
| 流通市值：12.62亿 | | | 总市值：21.13亿 |
| 流通股本：5973.63万 | | | 总股本：1.00亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 492,343,391.1 | 436,943,414.18 | 76,119,952.75 | 842,437,861.81 |
| 营业收入 | 492,343,391.1 | 436,943,414.18 | 76,119,952.75 | 842,437,861.81 |
| 二、营业总成本 | 465,870,677.19 | 409,447,472.98 | 77,757,539.66 | 738,906,852.3 |
| 营业成本 | 393,756,754.41 | 356,362,849.74 | 56,998,321.46 | 612,747,631.63 |
| 税金及附加 | 3,012,045.35 | 1,897,578.9 | 532,684.6 | 5,880,475.02 |
| 销售费用 | 36,511,363.41 | 27,631,241.24 | 9,455,099.89 | 53,564,035.87 |
| 管理费用 | 21,863,945.08 | 15,734,219.05 | 5,892,516.91 | 37,257,638.8 |
| 研发费用 | 15,071,489.98 | 11,143,197.52 | 5,265,641.53 | 29,870,008.27 |
| 财务费用 | -4,344,921.04 | -3,321,613.47 | -386,724.73 | -412,937.29 |
| 其中:利息费用 | 4,400,271.22 | 3,099,061.57 | - | 4,201,835 |
| 其中:利息收入 | 9,214,293.41 | 6,805,441.59 | - | 5,140,764.77 |
| 加:投资收益 | - | - | 1,360,039.53 | 1,203,395.3 |
| 资产处置收益 | 31,789.3 | 6,971.37 | - | 17,822,454.4 |
| 资产减值损失(新) | 180,456.75 | -228,104.33 | 94,014.69 | -712,776.15 |
| 信用减值损失(新) | -7,876,300.95 | -12,013,629.52 | 10,521,209.75 | -36,246,073.52 |
| 其他收益 | 2,784,840.93 | 1,396,289.75 | 281,243.73 | 11,707,178.29 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 21,593,499.94 | 16,657,468.47 | 10,618,920.79 | 97,305,187.83 |
| 加:营业外收入 | 720,644.53 | 375,464.49 | 104,826.79 | 1,073,967.94 |
| 减:营业外支出 | 116,388.09 | 98,755.41 | 27,056.71 | 3,513,275.47 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 22,197,756.38 | 16,934,177.55 | 10,696,690.87 | 94,865,880.3 |
| 减:所得税费用 | 2,151,451.69 | 1,520,489.48 | -10,697.53 | 11,768,707.19 |
| 六、净利润 | 20,046,304.69 | 15,413,688.07 | 10,707,388.4 | 83,097,173.11 |
| 持续经营净利润 | 20,046,304.69 | 15,413,688.07 | 10,707,388.4 | 83,097,173.11 |
| 归属于母公司股东的净利润 | 20,046,304.69 | 15,413,688.07 | 10,707,388.4 | 83,097,173.11 |
| (一)基本每股收益 | 0.2 | 0.15 | 0.11 | 0.97 |
| (二)稀释每股收益 | 0.2 | 0.15 | 0.11 | 0.97 |
| 八、其他综合收益 | -127,650.4 | -175,027.07 | 0 | -463,324.91 |
| 归属于母公司股东的其他综合收益 | -127,650.4 | -175,027.07 | 0 | -463,324.91 |
| 九、综合收益总额 | 19,918,654.29 | 15,238,661 | 10,707,388.4 | 82,633,848.2 |
| 归属于母公司股东的综合收益总额 | 19,918,654.29 | 15,238,661 | 10,707,388.4 | 82,633,848.2 |
| 归属于少数股东的综合收益总额 | - | - | 0 | - |
| 公告日期 | 2024-10-24 | 2024-08-28 | 2024-04-24 | 2024-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |